Patents by Inventor Andre Warnecke

Andre Warnecke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations Of Albumin-Based Drug Delivery Systems
    Publication number: 20180028679
    Abstract: The present invention relates to a composition comprising at least two different albumin-based drug delivery systems, as well as to a pharmaceutical composition comprising said composition.
    Type: Application
    Filed: September 25, 2017
    Publication date: February 1, 2018
    Inventors: Felix Kratz, Andre Warnecke
  • Combinations of albumin-based drug delivery systems
    Patent number: 9801949
    Abstract: The present invention relates to a composition comprising at least two different albumin-based drug delivery systems, as well as to a pharmaceutical composition comprising said composition.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: October 31, 2017
    Assignee: KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
    Inventors: Felix Kratz, Andre Warnecke
  • COMBINATIONS OF ALBUMIN-BASED DRUG DELIVERY SYSTEMS
    Publication number: 20150023912
    Abstract: The present invention relates to a composition comprising at least two different albumin-based drug delivery systems, as well as to a pharmaceutical composition comprising said composition.
    Type: Application
    Filed: February 21, 2013
    Publication date: January 22, 2015
    Inventors: Felix Kratz, Andre Warnecke
  • Prodrugs
    Patent number: 8642555
    Abstract: The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: February 4, 2014
    Assignee: KTB Tumorforschungsgesellschaft mbH
    Inventors: Felix Kratz, Andre Warnecke, Bakheet Elsadek
  • PRODRUGS
    Publication number: 20120094892
    Abstract: The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.
    Type: Application
    Filed: March 9, 2010
    Publication date: April 19, 2012
    Applicant: KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
    Inventors: Felix Kratz, Andre Warnecke, Bakheet Elsadek
  • PROTEIN-BINDING METHOTREXATE DERIVATIVES, AND MEDICAMENTS CONTAINING THE SAME
    Publication number: 20100041615
    Abstract: The invention relates to methotrexate derivatives which contain a protein-binding group and can be enzymatically cleaved in the body such that the active substance or a low-molecular active substance derivative is released. Also disclosed is a method for producing methotrexate derivatives, the use thereof, and medicaments comprising methotrexate derivative.
    Type: Application
    Filed: July 25, 2007
    Publication date: February 18, 2010
    Inventors: Felix Kratz, Andre Warnecke
  • Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands
    Publication number: 20060089341
    Abstract: The invention concerns low-molecular platinum complexes containing cyclobutane-1,1-dicarboxylate ligands that contain a protein-binding group.
    Type: Application
    Filed: March 18, 2004
    Publication date: April 27, 2006
    Inventors: Felix Kratz, Andre Warnecke